Top Healthcare Market Research Companies in USA (2026 Guide)

BioNixus is a global market research and insights firm headquartered in Sheridan, Wyoming (USA) with offices in London (UK), combining 15+ years of experience with full-spectrum capability across pharmaceutical, healthcare, and consumer research. BioNixus serves US pharmaceutical and biotech clients with primary research designed around the FDA-regulated, multi-payer US market: physician and specialist surveys across major AMCs (Mayo Clinic, Cleveland Clinic, MSKCC, Johns Hopkins, UCSF, MGH) and community IDN networks; KOL identification and influence mapping by therapy area; PBM and CMS payer research covering UnitedHealth/Optum, CVS/Caremark, Express Scripts/Cigna, and Medicare Part B/D; IRA drug negotiation impact research; HEOR and real-world evidence generation; and competitive intelligence for launch planning and lifecycle management. All US studies are designed and executed under IRB/OHRP compliance (45 CFR Part 46) and HIPAA/HITECH data privacy standards.

IQVIA is the world's largest healthcare data and analytics company, headquartered in the US with comprehensive prescription audit data, claims analytics, and real-world evidence capabilities. IQVIA's core US value is its proprietary data infrastructure — IQVIA National Prescription Audit (NPA), IQVIA Xponent prescriber data, longitudinal patient claims panels, and hospital charge master data — providing deep visibility into US prescribing patterns and treatment pathways across commercial and government payer segments. IQVIA's primary research capabilities supplement its data products for attitudinal and qualitative insights. Best suited for clients needing prescription data, RWE platforms, or sales force analytics rather than primary qualitative research or payer strategy.

Ipsos Healthcare operates across the US market within Ipsos's global network, supporting pharmaceutical and consumer health clients with physician attitude-and-usage studies, patient research, disease awareness studies, and advertising concept testing. Ipsos brings strong methodological rigour, large consumer panel infrastructure, and the scale for nationally representative US quantitative studies across diverse patient and caregiver populations. The Ipsos Healthcare division provides dedicated pharmaceutical research expertise within the broader Ipsos network; pharma-specific capabilities depend on the research team assigned.

Kantar Health supports US pharmaceutical and consumer health clients with brand health tracking, patient perception research, and disease awareness studies. Kantar's primary US strength is its established consumer and patient panel infrastructure — making it the strongest partner for large-scale quantitative consumer health brand tracking, longitudinal patient panels, and FMCG health research. For prescription pharma, physician research, and market access, Kantar's generalist consumer panel capabilities need to be supplemented with specialist HCP recruitment and qualitative depth.

M3 Global Research provides physician panel access and digital survey capabilities for the US healthcare market, enabling rapid quantitative studies with verified US physicians across specialties through their online physician community. M3's model focuses on online physician panels and self-completion surveys rather than in-depth qualitative research or complex market access strategy. Best suited for fast-turnaround HCP attitude-and-usage surveys, concept testing, and quantitative market sizing where online physician access is the priority. M3's US panel covers the major specialties represented in US ambulatory and hospital settings.

RTI Health Solutions (part of RTI International) is a leading US-based health economics and outcomes research firm specialising in PRO instrument development, cost-effectiveness modeling, burden of disease research, and payer evidence generation. RTI's strength is in the evidence development and regulatory science space — PRO development for FDA label claims, payer dossier evidence, and ICER pre-submission analysis. RTI is best suited for clients requiring HEOR, outcomes research, or regulatory evidence development rather than primary commercial market research, KOL mapping, or payer interview programs.

Decision Resources Group (now part of Clarivate) provides secondary pharmaceutical and medical device intelligence for the US market, including epidemiology data, treatment algorithm mapping, pipeline tracking, and competitive landscape analysis. DRG's US healthcare coverage spans oncology, cardiovascular, diabetes, respiratory, immunology, and rare diseases — serving commercial strategy and launch planning teams with data-led secondary market context. DRG does not conduct custom primary research; its value is proprietary secondary intelligence and analytics complementing fieldwork from primary research specialists like BioNixus.